Menu Close

How Anthropic’s IPO gets priced, and why its valuation has two numbers

A clear laboratory glass funnel with a wide cone and a short straight neck stands above a mid olive gold field as many small flat unmarked order chips cascade in from the left and pile inside it, with a thin trickle of chips falling toward a separate solid unmarked gold ingot on the floor below the spout, and the official Anthropic mark at left

When Anthropic sets a final price for its initial public offering, the same $70 to $78 range in its prospectus can be read as two different company values. One widely cited figure, about $1.02 trillion at the top of the range, is based on shares outstanding after the deal. Another, about $1.4 trillion, is a fully diluted figure reported by Bloomberg and CNBC. The gap is a second share count, not a second offering price.

As of Monday, Nov. 16, Anthropic had not filed a later amendment to its registration statement or a pricing prospectus, so the $70 to $78 range remains the latest official estimate. Pricing is still expected on Wednesday, Nov. 18, and trading as ANT on Nasdaq on Thursday, Nov. 19, according to a free writing prospectus that reproduces the company’s IPO website, dates also reported on Monday by CNBC. In a livestreamed conversation with JPMorgan Chase chief executive Jamie Dimon on Nov. 13, chief executive Dario Amodei said Anthropic wants to “underpromise and overdeliver,” according to Yahoo Finance.

Anthropic’s latest registration statement, Amendment No. 2 to its Form S-1, dated Nov. 10, still estimates the price at $70 to $78 a share for 825 million Class A shares, of which about 801.4 million would be sold by the company and about 23.6 million by selling stockholders. AI Tech Daily has reported those terms.

The roadshow and the book

The website prospectus says the process began with a roadshow on Nov. 10. The SEC’s Office of Investor Education and Advocacy, in an investor bulletin on IPOs, describes what comes next as the assembly of an “order book.” Underwriters collect “indications of interest” that list how many shares a prospective investor would like to buy and at what price, and use them, with valuation analysis and market conditions, to recommend a price that the company ultimately determines, the bulletin says. Anthropic’s FAQ says the final price is expected to be determined on Nov. 18 based on “regulatory clearance, investor demand and market conditions.” Goldman Sachs and Morgan Stanley are leading the offering.

Those indications are not contracts. Actual sales are not permitted until the registration statement is effective. Anthropic’s prospectus makes the point in a narrower case: certain directors and affiliated entities have indicated interest in buying up to $303 million of Class A shares at the offering price, but “these indications of interest are not binding agreements or commitments to purchase,” the filing says.

Oversubscription, allocation, and the greenshoe

Demand figures circulating ahead of pricing count those indications, not completed purchases. On Nov. 12, Bloomberg reported orders of about six times the shares available, and a Reuters account the next day, citing its own sources, said the book was six times oversubscribed by the end of that Thursday. The people cited said demand could change.

After the price is set, underwriters decide who receives shares. Anthropic’s filing says shares will be offered subject to “the underwriters’ right to reject any order in whole or in part.” Bloomberg reported that bankers told prospective investors that Anthropic would prioritize existing backers, a preference not stated as a formal rule in the prospectus sections reviewed here.

The $70 to $78 figures are an estimated range, not the final price. As of Nov. 16, Anthropic had not filed a later S-1/A to amend the range. A European prospectus approved by Germany’s BaFin says the U.S. range “may be varied from time to time.”

Separately, Anthropic will grant the underwriters an option, exercisable for 30 days from the date of the prospectus, to purchase up to an additional 123.75 million Class A shares from the company at the offering price, less the underwriting discount, “solely for the purpose of covering over-allotments, if any.” The option, equal to 15% of the base offering, is commonly called a greenshoe.

Why the valuation has two numbers

The prospectus says that after the offering and a concurrent private placement, and assuming the $74 midpoint of the range and no exercise of the underwriters’ option, about 13.09 billion shares would be outstanding. Reuters, using shares outstanding listed in the filing, put the top of the range at up to $1.02 trillion. Multiplying that outstanding count by $78 produces about $1.02 trillion. That count does not include all options, restricted stock units, or other reserved shares.

Bloomberg reported a fully diluted valuation target of about $1.4 trillion, and CNBC put the fully diluted figure at up to $1.405 trillion at the top of the range. The S-1/A does not print a single official fully diluted valuation.

The $26 billion Class N placement, and lock-ups

Immediately after the offering, Google, Nvidia, AMD, Broadcom, Micron, Microsoft, and TSMC Partners have agreed to buy, severally and not jointly, an aggregate of $26.0 billion of Class N common stock from Anthropic in a private placement at the IPO price, or about 351.4 million shares at the $74 midpoint. The shares will not be registered in the IPO, and they “will not be subject to any market standoff agreement or lock-up agreement,” the filing says. They will be “restricted securities.”

Lock-up and market standoff agreements keep most existing holders from selling immediately after a listing. Anthropic says directors, officers, and the holders of substantially all of its capital stock have agreed to transfer restrictions. For most holders, the period runs for up to 180 days after the prospectus date, or earlier around the release of results for the quarter ending March 31, 2027. For the co-founders and certain stockholders holding more than 0.5% of fully diluted shares before the offering, it can run for up to 365 days. Up to 10% of lock-up securities held by non-founder directors, officers, and current and former employees and consultants may be sold beginning on the first trading day, the filing says. The Class N placement sits outside those lock-ups, even though resale remains restricted under the Securities Act.

Story so far

Sources

0 0 votes
Article Rating
Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x